11 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ACRA-CUT WIRE PASS DRILL

FDA 510(k)
FDA Class 2 ·Neurology

Kyocera Medical Technologies, Inc.

FDA UDI
KYOCERA MEDICAL TECHNOLOGIES, INC.·00841523154043·Tesera X Angled Trial, 60mm x 18mm x 12mm x 0°

SPECTRUM VENTRICULAR CATHETER

FDA 510(k)
FDA Class 2 ·Neurology

ADI Cervical Interbody Fusion Device

FDA 510(k)
FDA Class 2 ·Orthopedic

PRECISION QID

FDA Adverse Event
Malfunction ·ABBOTT DIABETES CARE INC·Product code NBW·January 26, 2017

PRECISION XTRA

FDA Adverse Event
Malfunction ·ABBOTT DIABETES CARE INC·Product code NBW·January 26, 2017

TELIGEN

FDA Adverse Event
Injury ·GUIDANT CRM CLONMEL IRELAND·Product code LWS·January 11, 2013

GOLDLINE® PUSH BUTTON PENCIL

FDA Adverse Event
Injury ·CONMED ELECTROSURGERY·Product code GEI·December 1, 2010

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·July 3, 2014

Covidien Trellis-8 Peripheral Infusion System. Models CVT808015, CVT808025, CVT812015, and CVT812025. The following models are not offered for sale in the US: EVT808015, EVT808025, EVT812015, and EVT812025 Sterile EO. Product Usage: Intended for controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature.

FDA Enforcement
Class I ·Terminated·Covidien·February 11, 2015

Covidien Trellis 6 and Trellis 8 Peripheral Infusion Systems, Sterile EO, Rx only. Models BVT608010V01, BVT608030V01, BVT612010V01, BVT612030V01, CVT808015, CVT808025, CVT812015, CVT812025, EVT808015, EVT808025, EVT812015, EVT812025, BVT808015, BVT808030, BVT812015, BVT812030, EUT808015, EUT808030, EUT812015, EUT812030. Product Usage: The Trellis 6 and Trellis 8 peripheral infusion system is intended for controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature.

FDA Enforcement
Class II ·Terminated·Medtronic Inc. Cardiac Rhythm Disease Management·April 8, 2015